University of California, San Francisco: Opioid-Related Disorders trials

The registry lists 10 Opioid-Related Disorders studies with University of California, San Francisco as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 3Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject DrugsNot yet recruitingNCT07631559Not applicable
• Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine InitiationNot yet recruitingNCT07469501Phase 4
• Individualized Adaptive Deep Brain Stimulation in Opioid Use DisorderRecruitingNCT07214467Not applicable
• Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency DepartmentRecruitingNCT06872190Not applicable
• The Effect of Chronic Pain on Delay Discounting in Methadone PatientsTerminatedNCT04473950Phase 1Results posted
• Empower Opioid Misuse & Chronic PainCompletedNCT04184362Not applicableResults posted
• Acute Pain Management in Patients on Opioid Replacement TherapyTerminatedNCT03933865Phase 1
• Cocaine Opioid Oxytocin Option - LimitedCompletedNCT02028533Phase 1
• Methadone Oxytocin OptionCompletedNCT01728909Early Phase 1
• Integrating Buprenorphine Into the SFGH AIDS ProgramCompletedNCT00263458Phase 4